Abstract

It has emerged as a transformative tool in the field of oncology, revolutionizing cancer staging and influencing treatment decisions across diverse malignancies. This comprehensive review explores the profound impact of SLNB on the precision of staging and the subsequent therapeutic strategies employed in the oncological realm. SLNB, originally developed for melanoma and breast cancer, has dramatically redefined the landscape of nodal staging. The procedure involves the identification and biopsy of the sentinel lymph node, the first node in the lymphatic basin draining a primary tumor. Its role in precision staging is underscored by consistently high diagnostic accuracy rates, allowing for early detection of nodal metastases and informed therapeutic choices.